Category
Ruxolitinib
CAS Number
1911644-32-0
Molecular Formula
C₁₇H₂₀N₆O
Molecular Weight
324.39 g/mol
Synonym

Ruxolitinib-amide; 3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
Impurities manufacturer and Suppliers in Hyderabad india
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Ensure the safety and efficacy of your drug products with the Ruxolitinib Amide impurity (CAS: 1911644-32-0; Formula: C₁₇H₂₀N₆O; MW: 324.39 g/mol and chemical name 3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide) from Manasa Life Sciences. As an expert manufacturer and supplier  in Hyderabad, India, we utilize advanced HPLC, LCMS, NMR, and IR analytical tools to characterize this degradation product with high precision. Our synthesis and analytical R&D departments operate under stringent GMP and GDP mandates, strictly following EP, USP, USFDA, EMA, and ICH guidelines to ensure regulatory compliance. Every unit is shipped with an authoritative COA and MSDS, providing the critical chemical identification and stability data needed for your impurity profiling. We understand the high stakes of pharmaceutical quality control and provide the documentation necessary to support your stability studies and regulatory filings. By partnering with us, you gain access to high-purity reference materials, expert scientific support, and a commitment to maintaining the highest safety standards in the global pharmaceutical industry.